Cardiotrophin-1 (CT-1) is a protein encoded by the CTF1 gene in humans. It functions as a cytokine and acts as a 21.5 kDa cardiac hypertrophic factor. CT-1 belongs to the IL-6 cytokine family.

CTF1
Identifiers
AliasesCTF1, cardiotrophin 1, CT-1, CT1
External IDsOMIM: 600435; MGI: 105115; HomoloGene: 1016; GeneCards: CTF1; OMA:CTF1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001142544
NM_001330

NM_001301282
NM_001301283
NM_007795

RefSeq (protein)

NP_001136016
NP_001321

NP_001288211
NP_001288212
NP_031821

Location (UCSC)Chr 16: 30.9 – 30.9 MbChr 7: 127.31 – 127.32 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Tissue distribution

edit

CT-1 is highly expressed in the heart, skeletal muscle, prostate and ovary and to lower levels in lung, kidney, pancreas, thymus, testis and small intestine. [5]

Mode of action

edit

The protein exerts its cellular effects by interacting with the glycoprotein 130 (gp130)/leukemia inhibitory factor receptor beta (LIFR) heterodimer. In addition, CT-1 activates phosphatidylinositol 3-kinase (PI-3 kinase) in cardiac myocytes and enhances transcription factor NF-κB DNA -binding activities.

Clinical significance

edit

CT-1 is associated with the pathophysiology of heart diseases, including hypertension, myocardial infarction, valvular heart disease, and congestive heart failure.

Exogenous administration of CT-1 in rodents has been found to mimic the beneficial effects of exercise on the heart in a rodent model of severe right-sided heart failure.[6][7][8][9][10]

CT-1 is under formal development for the treatment of reperfusion injury.[11] It is or was also under development for treatment of acute kidney injury, diabetes mellitus, ischemia, liver failure, and obesity, but no recent development for these indications has been reported.[11]

See also

edit

References

edit
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000150281 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000042340 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "Recombinant human Cardiotrophin 1 protein (ab9838)". www.abcam.com. Retrieved 2017-08-09.
  6. Zelt JG, Chaudhary KR, Cadete VJ, Mielniczuk LM, Stewart DJ (May 2019). "Medical Therapy for Heart Failure Associated With Pulmonary Hypertension". Circ Res. 124 (11): 1551–1567. doi:10.1161/CIRCRESAHA.118.313650. PMID 31120820.
  7. Abdul-Ghani M, Suen C, Jiang B, Deng Y, Weldrick JJ, Putinski C, et al. (October 2017). "Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart". Cell Res. 27 (10): 1195–1215. doi:10.1038/cr.2017.87. PMC 5630684. PMID 28785017.
  8. How to trick your heart into thinking you exercise, retrieved 15 March 2026
  9. Watson SK (10 August 2017). "This protein makes your heart fit without actually exercising it". Popular Science. Retrieved 15 March 2026.
  10. Buguliskis JS (8 August 2017). "Fooling the Heart to Be Healthier". GEN - Genetic Engineering and Biotechnology News. Retrieved 15 March 2026.
  11. 1 2 "Digna Biotech/Biotecnol". AdisInsight. 2 October 2021. Retrieved 15 March 2026.
edit